These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16897983)

  • 1. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
    Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
    Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
    Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
    Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
    Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
    Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
    Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
    Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
    Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lentinan combination therapy for unresectable advanced gastric cancer.
    Higashi D; Seki K; Ishibashi Y; Egawa Y; Koga M; Sasaki T; Hirano K; Mikami K; Futami K; Maekawa T; Sudo M
    Anticancer Res; 2012 Jun; 32(6):2365-8. PubMed ID: 22641676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and efficacy of combination chemotherapy with S-1 and fractional Cisplatin for advanced gastric cancer.
    Takahashi T; Saikawa Y; Takaishi H; Takeuchi H; Wada N; Oyama T; Nakamura R; Kitagawa Y
    Anticancer Res; 2010 Sep; 30(9):3759-62. PubMed ID: 20944165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
    Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
    Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A recent trial of chemo-radiation with S-1 against gastric cancer].
    Saikawa Y; Kiyota T; Nakamura R; Wada N; Yoshida M; Kubota T; Kumai K; Shigematsu N; Kubo A; Kitajima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():99-105. PubMed ID: 16897982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
    Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
    Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
    Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
    Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.